Related Experiment Videos
[Peritoneal tuberculosis and continuous ambulatory peritoneal dialysis]
1Service de Néphrologie-Réanimation, Centre Hospitalier Universitaire, Dijon.
Nephrologie
|January 1, 1993
Summary
Peritoneal tuberculosis is a severe complication in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Early diagnosis via omental biopsy is crucial for improving outcomes in these immunocompromised individuals.
Area of Science:
- Nephrology
- Infectious Diseases
- Pathology
Background:
- Uremic patients exhibit depressed immunity, increasing tuberculosis risk tenfold.
- Extrapulmonary tuberculosis accounts for 40% of manifestations in uremic patients, with peritoneal involvement in 6%.
Observation:
- This report details a new case of peritoneal tuberculosis in a continuous ambulatory peritoneal dialysis (CAPD) patient, adding to 17 previously reported cases.
- Diagnosis is challenging due to difficulty differentiating from other lymphocytic peritonitis causes and slow mycobacterial growth in cultures.
Findings:
- Peritoneal tuberculosis carries a severe prognosis, with 8 reported deaths, 3 directly attributed to the disease.
- Omental biopsy is proposed as a valuable tool for early diagnosis of lymphocytic peritonitis of unknown origin.
- Antitubercular drug side effects, including optical neuritis and liver toxicity, can occur despite dose adjustments.
Implications:
- Early diagnosis of peritoneal tuberculosis is critical for timely treatment and improved patient survival.
- Omental biopsy should be considered for lymphocytic peritonitis cases where the cause remains unclear.
- CAPD may not always require discontinuation, even with ultrafiltration loss, in managing peritoneal tuberculosis.